Your session is about to expire
← Back to Search
Intra-Aortic Mechanical Circulatory Support
Aortix System for Cardio-Renal Syndrome
N/A
Waitlist Available
Research Sponsored by Procyrion
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 30 days
Awards & highlights
Study Summary
This trial studied the safety and effectiveness of the Aortix system for people with cardiorenal syndrome.
Eligible Conditions
- Cardio-Renal Syndrome
- Congestive Heart Failure
- Heart Failure
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 30 days
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~30 days
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
BNP (Brain natriuretic peptide)
Device Performance
Effectiveness
+3 moreTrial Design
1Treatment groups
Experimental Treatment
Group I: Aortix DeviceExperimental Treatment1 Intervention
Aortix Pump, Aortix Delivery System, Introducer Set, Aortix Control System, Aortix Retrieval System
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Aortix System
2021
N/A
~30
Find a Location
Who is running the clinical trial?
Procyrion Australia Pty LtdUNKNOWN
1 Previous Clinical Trials
20 Total Patients Enrolled
ProcyrionLead Sponsor
2 Previous Clinical Trials
288 Total Patients Enrolled
1 Trials studying Cardio-Renal Syndrome
268 Patients Enrolled for Cardio-Renal Syndrome
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
How many locations are being utilized for the execution of this clinical trial?
"The clinical trial is being conducted in cities such as Chicago, Detroit and Tampa with an additional 12 sites nationwide. The exact locations are University of Chicago (Chicago), Henry Ford Health System (Detroit) and University of South Florida (Tampa)."
Answered by AI
Are new participants still eligible for this experiment?
"This trial, as reported on clinicaltrials.gov is no longer recruiting patients; the initial posting was made on February 5th 2021 and the last update occurred October 7th 2022. Despite this study being completed, there are over two thousand other studies currently searching for participants."
Answered by AI
Share this study with friends
Copy Link
Messenger